%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Ida Bergström, Anna K. Lundberg, Simon Jönsson, Eva Särndahl, Jan Ernerudh, Lena Jonasson
Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 10 0 R/Annots 11 0 R/Contents 12 0 R/TrimBox[0 0 612 792]>>
endobj
11 0 obj
[13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R]
endobj
13 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref001)>>
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref002)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref003)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref004)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref005)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref006)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref011)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref012)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref013)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref014)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref015)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref012)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref016)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref018)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref016)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref017)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref018)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref019)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref020)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref021)>>
endobj
33 0 obj
<>/Border[0 0 0]/A 34 0 R>>
endobj
34 0 obj
<>
endobj
12 0 obj
[35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R]
endobj
35 0 obj
<>stream
q
0.83 0.64 0.02 0 k
538.8094 674.9858 m
543.5717 674.9858 l
h
f*
487.4457 662.0031 m
492.2079 662.0031 l
h
f*
496.6866 662.0031 m
501.3921 662.0031 l
h
f*
547.8803 635.9811 m
552.6425 635.9811 l
h
f*
557.0646 635.9811 m
561.8268 635.9811 l
h
f*
338.0031 596.9764 m
342.7654 596.9764 l
h
f*
347.9244 596.9764 m
357.4488 596.9764 l
h
f*
391.9181 558.0283 m
401.3858 558.0283 l
h
f*
405.8646 558.0283 m
415.389 558.0283 l
h
f*
240.7181 519.0236 m
250.2425 519.0236 l
h
f*
254.7213 519.0236 m
264.189 519.0236 l
h
f*
203.4142 466.9795 m
212.9386 466.9795 l
h
f*
203.4142 441.0142 m
212.9386 441.0142 l
h
f*
218.0976 441.0142 m
227.622 441.0142 l
h
f*
231.9307 402.0094 m
241.4551 402.0094 l
h
f*
555.137 375.9874 m
564.6614 375.9874 l
h
f*
200.0126 363.0047 m
209.537 363.0047 l
h
f*
406.6583 350.022 m
416.126 350.022 l
h
f*
484.1008 311.0173 m
493.6252 311.0173 l
h
f*
498.0472 311.0173 m
507.5717 311.0173 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Annexin)Tj
3.702 0 Td
(A1)Tj
1.3833 0 Td
(\(AnxA1\),)Tj
3.9798 0 Td
(formerly)Tj
3.702 0 Td
(called)Tj
2.5228 0 Td
(lipocortin-1,)Tj
5.2271 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.6576 0 Td
(key)Tj
1.5931 0 Td
(player)Tj
2.6645 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(resolution)Tj
4.2802 0 Td
(of)Tj
1.0148 0 Td
(inflam-)Tj
-34.0778 -1.3039 Td
(mation)Tj
3.0954 0 Td
(and)Tj
1.7291 0 Td
(known)Tj
3.0047 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(mediator)Tj
3.8721 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(anti-inflammatory)Tj
7.6081 0 Td
(effects)Tj
2.7213 0 Td
(of)Tj
1.0148 0 Td
(glucocorticoids)Tj
6.3439 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.6044 0 Td
(It)Tj
0.856 0 Td
(is)Tj
-35.9997 -1.2982 Td
(abundantly)Tj
4.7451 0 Td
(expressed)Tj
4.0932 0 Td
(in)Tj
1.0375 0 Td
(innate)Tj
2.7382 0 Td
(immune)Tj
3.6284 0 Td
(cells)Tj
1.9218 0 Td
(under)Tj
2.6192 0 Td
(normal)Tj
3.1465 0 Td
(conditions)Tj
4.473 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2643 0 Td
(3)Tj
0 g
(].)Tj
1.2585 0 Td
(In)Tj
1.1112 0 Td
(experimental)Tj
-32.0369 -1.2983 Td
(models,)Tj
3.3278 0 Td
(AnxA1)Tj
3.0784 0 Td
(or)Tj
1.0998 0 Td
(AnxA1-derived)Tj
6.4233 0 Td
(peptides)Tj
3.5546 0 Td
(exert)Tj
2.2054 0 Td
(a)Tj
0.6519 0 Td
(broad)Tj
2.5682 0 Td
(range)Tj
2.4605 0 Td
(of)Tj
1.0148 0 Td
(anti-inflammatory)Tj
7.6081 0 Td
(effects)Tj
2.7269 0 Td
(in)Tj
-36.7197 -1.3039 Td
(monocytes,)Tj
4.7848 0 Td
(involving)Tj
3.9798 0 Td
(transcriptional)Tj
6.1171 0 Td
(changes)Tj
3.4016 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(rapid)Tj
2.3358 0 Td
(post-translational)Tj
7.2509 0 Td
(effects)Tj
2.7269 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(5)Tj
0 g
(].)Tj
-35.7049 -1.2983 Td
(A)Tj
0.9014 0 Td
(number)Tj
3.4185 0 Td
(of)Tj
1.0148 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.058 0 Td
(also)Tj
1.7688 0 Td
(shown)Tj
2.8516 0 Td
(that)Tj
1.7745 0 Td
(glucocorticoids)Tj
6.3439 0 Td
(induce)Tj
2.9366 0 Td
(de)Tj
1.1736 0 Td
(novo)Tj
2.2337 0 Td
(synthesis)Tj
3.8267 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
(as)Tj
-36.1244 -1.2982 Td
(translocation)Tj
5.4651 0 Td
(of)Tj
1.0148 0 Td
(AnxA1)Tj
3.0784 0 Td
(to)Tj
1.0205 0 Td
(the)Tj
1.474 0 Td
(cell)Tj
1.559 0 Td
(surface)Tj
3.0501 0 Td
(in)Tj
1.0318 0 Td
(peripheral)Tj
4.32 0 Td
(blood)Tj
2.5171 0 Td
(mononuclear)Tj
5.5729 0 Td
(cells)Tj
1.9219 0 Td
(\(PBMCs\))Tj
3.9571 0 Td
(or)Tj
-35.9827 -1.304 Td
(isolated)Tj
3.2824 0 Td
(monocytes/macrophages)Tj
10.1764 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
3.0727 0 Td
(The)Tj
1.7801 0 Td
(expression)Tj
4.4674 0 Td
(of)Tj
1.0148 0 Td
(AnxA1)Tj
3.0784 0 Td
(in)Tj
1.0318 0 Td
(circulating)Tj
4.4957 0 Td
(PBMCs)Tj
3.2769 0 Td
(may)Tj
-35.6766 -1.2982 Td
(thus)Tj
1.9332 0 Td
(serve)Tj
2.2563 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(indicator)Tj
3.8608 0 Td
(of)Tj
1.0148 0 Td
(anti-inflammatory)Tj
7.6081 0 Td
(actions)Tj
3.0614 0 Td
(and)Tj
1.7291 0 Td
(glucocorticoid)Tj
5.9811 0 Td
(sensitivity.)Tj
-28.4653 -1.2983 Td
(An)Tj
1.457 0 Td
(imbalance)Tj
4.3199 0 Td
(between)Tj
3.532 0 Td
(pro-)Tj
1.9615 0 Td
(and)Tj
1.7348 0 Td
(anti-inflammatory)Tj
7.6025 0 Td
(actions)Tj
3.0614 0 Td
(is)Tj
0.8504 0 Td
(believed)Tj
3.4923 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1508 0 Td
(important)Tj
4.2803 0 Td
(in)Tj
-35.6652 -1.2983 Td
(the)Tj
1.4683 0 Td
(development)Tj
5.4085 0 Td
(and)Tj
1.7291 0 Td
(control)Tj
3.1237 0 Td
(of)Tj
1.0148 0 Td
(atherosclerosis)Tj
6.1058 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(13)Tj
0 g
(].)Tj
1.7348 0 Td
(Several)Tj
3.0501 0 Td
(components)Tj
5.176 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(immune)Tj
-33.029 -1.3039 Td
(system)Tj
2.9366 0 Td
(are)Tj
1.4514 0 Td
(involved)Tj
3.6453 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(inflammatory)Tj
5.7089 0 Td
(process)Tj
3.1862 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(arterial)Tj
3.0671 0 Td
(wall,)Tj
2.0579 0 Td
(including)Tj
4.0365 0 Td
(early)Tj
2.1543 0 Td
(recruit-)Tj
-33.2331 -1.2982 Td
(ment)Tj
2.3073 0 Td
(and)Tj
1.7292 0 Td
(activation)Tj
4.1555 0 Td
(of)Tj
1.0148 0 Td
(monocytes)Tj
4.5638 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4683 0 Td
(intima)Tj
2.8517 0 Td
(followed)Tj
3.651 0 Td
(by)Tj
1.1849 0 Td
(induction)Tj
4.1328 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(adaptive)Tj
3.5773 0 Td
(immune)Tj
-34.1459 -1.2983 Td
(response)Tj
3.7303 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7405 0 Td
(15)Tj
0 g
(].)Tj
1.7348 0 Td
(The)Tj
1.7801 0 Td
(pro-inflammatory)Tj
7.4551 0 Td
(milieu)Tj
2.7723 0 Td
(in)Tj
1.0374 0 Td
(atherosclerotic)Tj
6.1002 0 Td
(lesions)Tj
2.9366 0 Td
(is)Tj
0.8447 0 Td
(also)Tj
1.7689 0 Td
(mirrored)Tj
3.8777 0 Td
(in)Tj
-35.7786 -1.3039 Td
(the)Tj
1.4683 0 Td
(circulation)Tj
4.5354 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(atherosclerotic)Tj
6.1058 0 Td
(disease.)Tj
3.2428 0 Td
(Several)Tj
3.0501 0 Td
(studies)Tj
2.982 0 Td
(have)Tj
2.0636 0 Td
(described)Tj
4.0479 0 Td
(raised)Tj
-33.8738 -1.2983 Td
(plasma)Tj
3.033 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(inflammatory)Tj
5.7033 0 Td
(cytokines)Tj
4.0025 0 Td
(and)Tj
1.7291 0 Td
(enhanced)Tj
4.0762 0 Td
(activation)Tj
4.1556 0 Td
(of)Tj
1.0148 0 Td
(PBMCs)Tj
3.2768 0 Td
(in)Tj
1.0318 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
-34.7808 -1.2982 Td
(coronary)Tj
3.838 0 Td
(artery)Tj
2.5739 0 Td
(disease)Tj
3.016 0 Td
(\(CAD\),)Tj
3.2088 0 Td
(particularly)Tj
4.8132 0 Td
(in)Tj
1.0318 0 Td
(those)Tj
2.3414 0 Td
(with)Tj
1.9956 0 Td
(unstable)Tj
3.566 0 Td
(conditions)Tj
4.473 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(disease)Tj
-33.3465 -1.304 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
2.0749 0 Td
(The)Tj
1.7801 0 Td
(presence)Tj
3.7134 0 Td
(of)Tj
1.0148 0 Td
(anti-inflammatory)Tj
7.6081 0 Td
(mediators,)Tj
4.4561 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(other)Tj
2.3471 0 Td
(hand,)Tj
2.4831 0 Td
(is)Tj
0.8504 0 Td
(less)Tj
1.6101 0 Td
(well)Tj
1.8198 0 Td
(docu-)Tj
-32.5018 -1.2982 Td
(mented.)Tj
3.4865 0 Td
(Only)Tj
2.2167 0 Td
(a)Tj
0.652 0 Td
(few)Tj
1.6157 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.058 0 Td
(investigated)Tj
4.9889 0 Td
(the)Tj
1.4683 0 Td
(expression)Tj
4.4674 0 Td
(of)Tj
1.0148 0 Td
(AnxA1)Tj
3.0784 0 Td
(in)Tj
1.0375 0 Td
(atherosclerotic)Tj
6.1001 0 Td
(tissue)Tj
-35.172 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
3.5432 0 Td
(A)Tj
0.9071 0 Td
(proteomics)Tj
4.7112 0 Td
(analysis)Tj
3.3278 0 Td
(of)Tj
1.0148 0 Td
(human)Tj
3.0784 0 Td
(coronary)Tj
3.8381 0 Td
(arteries)Tj
3.1691 0 Td
(demonstrated)Tj
5.76 0 Td
(increased)Tj
4.0025 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
-35.7276 -1.2983 Td
(AnxA1)Tj
3.0784 0 Td
(in)Tj
1.0318 0 Td
(atherosclerotic)Tj
6.1057 0 Td
(tissue)Tj
2.4605 0 Td
(compared)Tj
4.2406 0 Td
(with)Tj
1.9956 0 Td
(non-atherosclerotic)Tj
8.0617 0 Td
(tissue)Tj
2.4548 0 Td
(and)Tj
1.7347 0 Td
(further)Tj
3.0274 0 Td
(valida-)Tj
-34.1912 -1.3039 Td
(tion)Tj
1.8425 0 Td
(by)Tj
1.1792 0 Td
(immunohistochemistry)Tj
9.615 0 Td
(suggested)Tj
4.0762 0 Td
(that)Tj
1.7802 0 Td
(AnxA1)Tj
3.0727 0 Td
(was)Tj
1.7008 0 Td
(expressed)Tj
4.0932 0 Td
(by)Tj
1.1849 0 Td
(macrophages)Tj
5.5048 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
-35.0813 -1.2982 Td
(intima)Tj
2.8516 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
2.0806 0 Td
(Interestingly,)Tj
5.4878 0 Td
(two)Tj
1.7122 0 Td
(studies)Tj
2.9877 0 Td
(of)Tj
1.0148 0 Td
(human)Tj
3.0784 0 Td
(carotid)Tj
3.0443 0 Td
(plaques)Tj
3.2372 0 Td
(reported)Tj
3.6623 0 Td
(that)Tj
1.7802 0 Td
(AnxA1)Tj
3.0727 0 Td
(expres-)Tj
-34.0098 -1.2983 Td
(sion)Tj
1.9048 0 Td
(was)Tj
1.6951 0 Td
(increased)Tj
4.0025 0 Td
(in)Tj
1.0318 0 Td
(plaques)Tj
3.2372 0 Td
(from)Tj
2.2053 0 Td
(asymptomatic)Tj
5.8564 0 Td
(patients)Tj
3.3675 0 Td
(compared)Tj
4.2463 0 Td
(with)Tj
1.9955 0 Td
(plaques)Tj
3.2372 0 Td
(from)Tj
2.2053 0 Td
(symp-)Tj
-34.9849 -1.3039 Td
(tomatic)Tj
3.2654 0 Td
(patients,)Tj
3.5943 0 Td
(thus)Tj
1.9333 0 Td
(indicating)Tj
4.2689 0 Td
(an)Tj
1.2019 0 Td
(association)Tj
4.6261 0 Td
(between)Tj
3.532 0 Td
(AnxA1)Tj
3.0784 0 Td
(and)Tj
1.7291 0 Td
(plaque)Tj
2.8743 0 Td
(stabilization)Tj
5.0683 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
-35.172 -1.2983 Td
(18)Tj
0 g
(].)Tj
1.7347 0 Td
(Recently,)Tj
3.8835 0 Td
(in)Tj
1.0375 0 Td
(vivo)Tj
1.9048 0 Td
(administration)Tj
6.1682 0 Td
(of)Tj
1.0148 0 Td
(AnxA1)Tj
3.0784 0 Td
(fragment)Tj
3.8664 0 Td
(Ac2-26)Tj
3.1068 0 Td
(was)Tj
1.7007 0 Td
(shown)Tj
2.846 0 Td
(to)Tj
1.0261 0 Td
(stabilize)Tj
-31.3679 -1.2983 Td
(advanced)Tj
3.9911 0 Td
(atherosclerotic)Tj
6.1058 0 Td
(lesions)Tj
2.931 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.6519 0 Td
(mouse)Tj
2.863 0 Td
(model)Tj
2.7439 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
-19.128 -1.3039 Td
(In)Tj
1.1111 0 Td
(the)Tj
1.4684 0 Td
(present)Tj
3.1634 0 Td
(study,)Tj
2.6192 0 Td
(we)Tj
1.3266 0 Td
(compared)Tj
4.2406 0 Td
(the)Tj
1.4684 0 Td
(expression)Tj
4.4673 0 Td
(of)Tj
1.0148 0 Td
(AnxA1)Tj
3.0784 0 Td
(in)Tj
1.0375 0 Td
(PBMCs)Tj
3.2768 0 Td
(from)Tj
2.2054 0 Td
(CAD)Tj
2.3017 0 Td
(patients)Tj
-33.9758 -1.2982 Td
(and)Tj
1.7291 0 Td
(healthy)Tj
3.1294 0 Td
(subjects)Tj
3.3789 0 Td
(and)Tj
1.7348 0 Td
(related)Tj
2.9423 0 Td
(it)Tj
0.788 0 Td
(to)Tj
1.0205 0 Td
(inflammatory)Tj
5.7089 0 Td
(status.)Tj
2.727 0 Td
(Since)Tj
2.3584 0 Td
(previous)Tj
3.651 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.0579 0 Td
(raised)Tj
-34.2139 -1.2983 Td
(the)Tj
1.4626 0 Td
(question)Tj
3.6567 0 Td
(about)Tj
2.4945 0 Td
(insufficient)Tj
4.7225 0 Td
(glucocorticoid)Tj
5.981 0 Td
(actions)Tj
3.0557 0 Td
(in)Tj
1.0318 0 Td
(CAD)Tj
2.3018 0 Td
(patients)Tj
3.3618 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(21)Tj
0 g
(],)Tj
1.7291 0 Td
(we)Tj
1.3267 0 Td
(also)Tj
1.7631 0 Td
(investi-)Tj
-34.6221 -1.3039 Td
(gated)Tj
2.3697 0 Td
(whether)Tj
3.4753 0 Td
(AnxA1)Tj
3.0784 0 Td
(expression)Tj
4.4617 0 Td
(in)Tj
1.0374 0 Td
(PBMCs)Tj
3.2769 0 Td
(correlated)Tj
4.2462 0 Td
(with)Tj
1.9956 0 Td
(cortisol)Tj
3.2031 0 Td
(levels,)Tj
2.6022 0 Td
(glucocorticoid)Tj
-29.7465 -1.2983 Td
(receptor)Tj
3.5546 0 Td
(\(GR\))Tj
2.2393 0 Td
(expression)Tj
4.4617 0 Td
(and)Tj
1.7292 0 Td
(glucocorticoid)Tj
5.9867 0 Td
(sensitivity.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 247.9748 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Material)Tj
3.959 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F0 1 Tf
-5.948 -1.4976 Td
(Study)Tj
2.7543 0 Td
(populations)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 212.9952 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(study)Tj
2.3924 0 Td
(population)Tj
4.5864 0 Td
(consisted)Tj
3.9402 0 Td
(of)Tj
1.0148 0 Td
(57)Tj
1.1735 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9955 0 Td
(stable)Tj
2.4888 0 Td
(CAD)Tj
2.3018 0 Td
(\(SCAD\))Tj
3.4639 0 Td
(and)Tj
1.7291 0 Td
(41)Tj
1.1679 0 Td
(healthy)Tj
3.1351 0 Td
(con-)Tj
-34.5371 -1.2982 Td
(trols.)Tj
2.228 0 Td
(We)Tj
1.61 0 Td
(also)Tj
1.7688 0 Td
(included)Tj
3.7077 0 Td
(a)Tj
0.6577 0 Td
(small)Tj
2.3244 0 Td
(group)Tj
2.6078 0 Td
(of)Tj
1.0148 0 Td
(10)Tj
1.1736 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(acute)Tj
2.33 0 Td
(coronary)Tj
3.8381 0 Td
(syndrome)Tj
4.2293 0 Td
(\(ACS\))Tj
2.7269 0 Td
(from)Tj
-35.5802 -1.3039 Td
(whom)Tj
2.7552 0 Td
(blood)Tj
2.5172 0 Td
(samples)Tj
3.3845 0 Td
(were)Tj
2.1203 0 Td
(collected)Tj
3.7417 0 Td
(within)Tj
2.812 0 Td
(24)Tj
1.1678 0 Td
(h)Tj
0.7484 0 Td
(from)Tj
2.2053 0 Td
(admission,)Tj
4.5411 0 Td
(always)Tj
2.8346 0 Td
(prior)Tj
2.2507 0 Td
(to)Tj
1.0261 0 Td
(coronary)Tj
-32.1049 -1.2983 Td
(angiography.)Tj
5.4368 0 Td
(In)Tj
1.1055 0 Td
(SCAD)Tj
2.7836 0 Td
(patients,)Tj
3.5943 0 Td
(blood)Tj
2.5115 0 Td
(samples)Tj
3.3845 0 Td
(were)Tj
2.1203 0 Td
(collected)Tj
3.7417 0 Td
(612)Tj
2.16 0 Td
(months)Tj
3.2825 0 Td
(after)Tj
2.0353 0 Td
(an)Tj
1.2075 0 Td
(ACS)Tj
-33.3635 -1.2983 Td
(event.)Tj
2.5908 0 Td
(All)Tj
1.4003 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(consecutively)Tj
5.5786 0 Td
(recruited)Tj
3.8551 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.4684 0 Td
(Department)Tj
5.091 0 Td
(of)Tj
1.0147 0 Td
(Cardiology,)Tj
4.8926 0 Td
(University)Tj
-32.3317 -1.2982 Td
(Hospital,)Tj
3.8437 0 Td
(Linko)Tj
0 Tc
1.9105 0 Td
()Tj
-0.004 Tc
0.4479 0 Td
(ping,)Tj
2.2394 0 Td
(Sweden.)Tj
3.5319 0 Td
(ACS)Tj
2.0409 0 Td
(was)Tj
1.7008 0 Td
(defined)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(non-ST)Tj
3.2599 0 Td
(elevation)Tj
3.821 0 Td
(myocardial)Tj
4.7055 0 Td
(infarction)Tj
-31.7421 -1.3039 Td
(based)Tj
2.4717 0 Td
(on)Tj
1.2756 0 Td
(typical)Tj
2.863 0 Td
(ECG)Tj
2.1657 0 Td
(changes)Tj
3.4015 0 Td
(\(ST-T)Tj
2.6135 0 Td
(segment)Tj
3.5547 0 Td
(depression)Tj
4.5297 0 Td
(and/or)Tj
2.9367 0 Td
(T-wave)Tj
3.1804 0 Td
(inversion\))Tj
4.3087 0 Td
(and)Tj
1.7291 0 Td
(ele-)Tj
-35.0303 -1.2983 Td
(vated)Tj
2.3584 0 Td
(troponins.)Tj
4.371 0 Td
(In)Tj
1.1055 0 Td
(post-ACS)Tj
4.0818 0 Td
(patients,)Tj
3.5887 0 Td
(Patients)Tj
3.4129 0 Td
(were)Tj
2.1203 0 Td
(not)Tj
1.576 0 Td
(included)Tj
3.7134 0 Td
(if)Tj
0.771 0 Td
(they)Tj
1.9275 0 Td
(were)Tj
2.1203 0 Td
(over)Tj
1.9786 0 Td
(75)Tj
1.1679 0 Td
(years)Tj
2.2677 0 Td
(of)Tj
-36.561 -1.2983 Td
(age,)Tj
1.7688 0 Td
(had)Tj
1.7064 0 Td
(severe)Tj
2.6759 0 Td
(heart)Tj
2.279 0 Td
(failure,)Tj
2.9991 0 Td
(immunologic)Tj
5.6239 0 Td
(disorders,)Tj
4.1612 0 Td
(neoplastic)Tj
4.2463 0 Td
(disease,)Tj
3.2428 0 Td
(evidence)Tj
3.7134 0 Td
(of)Tj
1.0148 0 Td
(acute)Tj
2.3243 0 Td
(or)Tj
-35.7559 -1.3039 Td
(recent)Tj
2.7099 0 Td
(\()Tj
/F10 1 Tf
0 Tc
(<)Tj
/F5 1 Tf
-0.004 Tc
1.3266 0 Td
(2)Tj
0.6973 0 Td
(months\))Tj
3.6226 0 Td
(infection,)Tj
4.0195 0 Td
(recent)Tj
2.7043 0 Td
(major)Tj
2.6135 0 Td
(trauma,)Tj
3.3278 0 Td
(surgery)Tj
3.1975 0 Td
(or)Tj
1.0942 0 Td
(revascularization)Tj
7.0015 0 Td
(procedure,)Tj
-32.3147 -1.2983 Td
(and)Tj
1.7291 0 Td
(treatment)Tj
4.1329 0 Td
(with)Tj
2.0012 0 Td
(immunosuppressive)Tj
8.2941 0 Td
(or)Tj
1.0999 0 Td
(anti-inflammatory)Tj
7.6024 0 Td
(agents)Tj
2.7553 0 Td
(\(except)Tj
3.1067 0 Td
(low-dose)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 445.3228 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Annexin)Tj
3.7701 0 Td
(A1)Tj
1.4244 0 Td
(in)Tj
0.9779 0 Td
(coronary)Tj
4.0394 0 Td
(artery)Tj
2.7355 0 Td
(disease)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01741)Tj
4.089 0 Td
(77)Tj
0 g
2.0906 0 Td
(March)Tj
2.9622 0 Td
(22,)Tj
1.5874 0 Td
(2017)Tj
34.3562 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
BT
66.402 0 Td
(16)Tj
ET
Q
endstream
endobj
56 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 10 0 R/Annots 58 0 R/Contents 59 0 R/TrimBox[0 0 612 792]>>
endobj
58 0 obj
[60 0 R 61 0 R]
endobj
60 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174177.ref022)>>
endobj
61 0 obj
<>/Border[0 0 0]/A 62 0 R>>
endobj
62 0 obj
<>
endobj
59 0 obj
[63 0 R 64 0 R 65 0 R 66 0 R]
endobj
63 0 obj
<>stream
q
0.83 0.64 0.02 0 k
454.2803 570.1039 m
463.8047 570.1039 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(aspirin\).)Tj
3.5489 0 Td
(As)Tj
1.2642 0 Td
(a)Tj
0.6577 0 Td
(healthy)Tj
3.1294 0 Td
(control)Tj
3.1238 0 Td
(group,)Tj
2.8346 0 Td
(age)Tj
1.542 0 Td
(and)Tj
1.7292 0 Td
(sex)Tj
1.4683 0 Td
(matched)Tj
3.6737 0 Td
(subjects)Tj
3.3789 0 Td
(from)Tj
2.211 0 Td
(the)Tj
1.4683 0 Td
(same)Tj
2.2564 0 Td
(area)Tj
1.8822 0 Td
(\(region)Tj
-34.1686 -1.3039 Td
(of)Tj
1.0147 0 Td
(O)Tj
0 Tc
0.1758 0.2211 Td
()Tj
-0.004 Tc
0.5669 -0.2211 Td
(stergo)Tj
0 Tc
1.9843 0 Td
()Tj
-0.004 Tc
0.4422 0 Td
(tland,)Tj
2.5001 0 Td
(Sweden\))Tj
3.6453 0 Td
(were)Tj
2.1203 0 Td
(randomly)Tj
4.1329 0 Td
(invited)Tj
3.0047 0 Td
(from)Tj
2.2054 0 Td
(the)Tj
1.474 0 Td
(Swedish)Tj
3.4866 0 Td
(Population)Tj
4.6317 0 Td
(Register)Tj
3.447 0 Td
(to)Tj
1.0261 0 Td
(par-)Tj
-35.858 -1.2982 Td
(ticipate)Tj
3.1464 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(study.)Tj
2.6135 0 Td
(The)Tj
1.7858 0 Td
(control)Tj
3.1181 0 Td
(subjects)Tj
3.3789 0 Td
(were)Tj
2.126 0 Td
(anamnestically)Tj
6.1568 0 Td
(healthy)Tj
3.1351 0 Td
(without)Tj
3.3278 0 Td
(fulfilling)Tj
3.6114 0 Td
(any)Tj
-34.9056 -1.2983 Td
(exclusion)Tj
3.9911 0 Td
(criteria,)Tj
3.2995 0 Td
(however)Tj
3.6113 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(statins)Tj
2.7893 0 Td
(or)Tj
1.0998 0 Td
(antihypertensive)Tj
6.8372 0 Td
(drugs)Tj
2.4718 0 Td
(for)Tj
1.3889 0 Td
(primary)Tj
3.4526 0 Td
(prevention)Tj
4.5808 0 Td
(was)Tj
-36.0678 -1.2983 Td
(allowed.)Tj
3.5149 0 Td
(The)Tj
1.7801 0 Td
(study)Tj
2.3925 0 Td
(was)Tj
1.6951 0 Td
(conducted)Tj
4.4277 0 Td
(in)Tj
1.0374 0 Td
(accordance)Tj
4.7339 0 Td
(with)Tj
2.0012 0 Td
(the)Tj
1.4683 0 Td
(ethical)Tj
2.8403 0 Td
(guidelines)Tj
4.2747 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(Declaration)Tj
-32.6549 -1.3039 Td
(of)Tj
1.0091 0 Td
(Helsinki,)Tj
3.8211 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(research)Tj
3.5546 0 Td
(protocol)Tj
3.5943 0 Td
(was)Tj
1.6952 0 Td
(approved)Tj
3.9684 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4684 0 Td
(Ethical)Tj
2.982 0 Td
(Review)Tj
3.0954 0 Td
(Board)Tj
2.6362 0 Td
(of)Tj
1.0148 0 Td
(Linko)Tj
0 Tc
1.9106 0 Td
()Tj
-0.004 Tc
0.4422 0 Td
(ping.)Tj
-35.5689 -1.2982 Td
(Written)Tj
3.3902 0 Td
(informed)Tj
3.9741 0 Td
(consent)Tj
3.3279 0 Td
(was)Tj
1.7007 0 Td
(obtained)Tj
3.7361 0 Td
(from)Tj
2.2053 0 Td
(all)Tj
1.1452 0 Td
(study)Tj
2.3868 0 Td
(participants.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 601.1716 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Numbers)Tj
4.2331 0 Td
(and)Tj
1.8661 0 Td
(proportions)Tj
5.1591 0 Td
(of)Tj
1.0441 0 Td
(circulating)Tj
4.6583 0 Td
(leukocyte)Tj
4.3937 0 Td
(subsets)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 584.2204 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Numbers)Tj
3.9628 0 Td
(of)Tj
1.0148 0 Td
(leukocytes,)Tj
4.6091 0 Td
(monocytes,)Tj
4.7905 0 Td
(CD4)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 362.5511 588.6425 cm
BT
/F5 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(+)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 369.0708 584.2204 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(T)Tj
0.8277 0 Td
(cells,)Tj
2.1486 0 Td
(CD8)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 417.6 588.6425 cm
BT
/F5 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(+)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 424.1196 584.2204 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(T)Tj
0.8333 0 Td
(cells,)Tj
2.143 0 Td
(and)Tj
1.7291 0 Td
(NK)Tj
1.6328 0 Td
(cells)Tj
1.9219 0 Td
(were)Tj
2.1203 0 Td
(analyzed)Tj
3.702 0 Td
(by)Tj
-36.4929 -1.3039 Td
(flow)Tj
1.9445 0 Td
(cytometry)Tj
4.269 0 Td
(in)Tj
1.0375 0 Td
(EDTA)Tj
2.8232 0 Td
(whole)Tj
2.6079 0 Td
(blood.)Tj
2.7383 0 Td
(As)Tj
1.2642 0 Td
(previously)Tj
4.354 0 Td
(described)Tj
4.0477 0 Td
([)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(],)Tj
2.0807 0 Td
(the)Tj
1.4683 0 Td
(number)Tj
3.4186 0 Td
(of)Tj
1.0148 0 Td
(cells/)Tj
/F11 1 Tf
[()]TJ
/F5 1 Tf
(L)Tj
-33.0687 -1.2982 Td
(was)Tj
1.6951 0 Td
(determined)Tj
4.8529 0 Td
(by)Tj
1.1848 0 Td
(using)Tj
2.3868 0 Td
(Trucount)Tj
/F11 1 Tf
[()]TJ
/F5 1 Tf
4.4901 0 Td
(tubes)Tj
2.3357 0 Td
(\(BD)Tj
1.8765 0 Td
(Biosciences,)Tj
5.0342 0 Td
(San)Tj
1.6781 0 Td
(Jose)Tj
0 Tc
1.2189 0.051 Td
()Tj
-0.004 Tc
0.4025 -0.051 Td
(,)Tj
0.4422 0 Td
(CA,)Tj
1.7915 0 Td
(USA\))Tj
2.4605 0 Td
(containing)Tj
4.524 0 Td
(an)Tj
-36.3738 -1.2983 Td
(exact)Tj
2.262 0 Td
(number)Tj
3.4186 0 Td
(of)Tj
1.0148 0 Td
(lyophilized)Tj
4.6204 0 Td
(beads)Tj
2.4718 0 Td
(and)Tj
1.7291 0 Td
(a)Tj
0.652 0 Td
(combination)Tj
5.3518 0 Td
(of)Tj
1.0147 0 Td
(monoclonal)Tj
5.0059 0 Td
(antibodies)Tj
4.3597 0 Td
(\(CD3-FITC)Tj
-31.9008 -1.3039 Td
(\(clone)Tj
2.7099 0 Td
(SK7\),)Tj
2.4094 0 Td
(CD4-PE-Cy7)Tj
5.5162 0 Td
(\(clone)Tj
2.7099 0 Td
(SK3\),)Tj
2.4094 0 Td
(CD8-APC-H7)Tj
5.9471 0 Td
(\(clone)Tj
2.7098 0 Td
(SK1\),)Tj
2.4094 0 Td
(CD45-PerCP)Tj
5.4992 0 Td
(\(clone)Tj
2.7042 0 Td
(2D1\),)Tj
-35.0245 -1.2983 Td
(CD56-PE)Tj
4.0478 0 Td
(\(clone)Tj
2.7099 0 Td
(NCAM16.2\),)Tj
5.4142 0 Td
(all)Tj
1.1452 0 Td
(from)Tj
2.2053 0 Td
(BD)Tj
1.5364 0 Td
(Biosciences.)Tj
5.0343 0 Td
(Briefly,)Tj
3.0726 0 Td
(antibodies)Tj
4.3597 0 Td
(were)Tj
2.1259 0 Td
(added)Tj
2.6589 0 Td
(to)Tj
-34.3102 -1.2982 Td
(whole)Tj
2.6078 0 Td
(blood)Tj
2.5115 0 Td
(and)Tj
1.7348 0 Td
(samples)Tj
3.3789 0 Td
(were)Tj
2.126 0 Td
(incubated)Tj
4.1782 0 Td
(for)Tj
1.3833 0 Td
(15)Tj
1.1735 0 Td
(min)Tj
1.8539 0 Td
(at)Tj
0.9524 0 Td
(room)Tj
2.4264 0 Td
(temperature)Tj
5.125 0 Td
(\(RT\))Tj
2.1316 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(dark.)Tj
-34.0891 -1.304 Td
(Erythrocytes)Tj
5.2781 0 Td
(were)Tj
2.1259 0 Td
(lysed)Tj
2.2337 0 Td
(with)Tj
1.9956 0 Td
(FACS)Tj
2.5682 0 Td
(Lysing)Tj
2.8573 0 Td
(Solution)Tj
3.5943 0 Td
(\(BD)Tj
1.8764 0 Td
(Biosciences\))Tj
5.1477 0 Td
(for)Tj
1.389 0 Td
(15)Tj
1.1678 0 Td
(min)Tj
1.8539 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.457 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
-35.5291 -1.2982 Td
(dark,)Tj
2.2734 0 Td
(and)Tj
1.7291 0 Td
(samples)Tj
3.3845 0 Td
(were)Tj
2.1203 0 Td
(then)Tj
2.0183 0 Td
(immediately)Tj
5.2044 0 Td
(analyzed)Tj
3.702 0 Td
(on)Tj
1.2756 0 Td
(a)Tj
0.6519 0 Td
(FACSCanto)Tj
5.0229 0 Td
(II)Tj
0.9014 0 Td
(\(BD)Tj
1.8765 0 Td
(Biosciences\))Tj
-30.1603 -1.2983 Td
(equipped)Tj
3.9288 0 Td
(with)Tj
1.9956 0 Td
(3)Tj
0.6973 0 Td
(lasers;)Tj
2.6418 0 Td
(a)Tj
0.6577 0 Td
(blue)Tj
1.9219 0 Td
(488)Tj
1.6497 0 Td
(nm,)Tj
1.8085 0 Td
(a)Tj
0.6576 0 Td
(red)Tj
1.5421 0 Td
(633)Tj
1.6441 0 Td
(nm)Tj
1.593 0 Td
(and)Tj
1.729 0 Td
(a)Tj
0.652 0 Td
(violet)Tj
2.4151 0 Td
(405)Tj
1.6498 0 Td
(nm.)Tj
1.8141 0 Td
(Acquisition)Tj
4.8756 0 Td
(of)Tj
1.0148 0 Td
(sam-)Tj
-34.8885 -1.2983 Td
(ples)Tj
1.7688 0 Td
(was)Tj
1.6951 0 Td
(stopped)Tj
3.3732 0 Td
(when)Tj
2.4038 0 Td
(30)Tj
1.1735 0 Td
(000)Tj
1.6441 0 Td
(cells)Tj
1.9219 0 Td
(were)Tj
2.1203 0 Td
(collected)Tj
3.7417 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(lymphocyte)Tj
4.8925 0 Td
(gate)Tj
1.8425 0 Td
(or,)Tj
1.3209 0 Td
(if)Tj
0.7767 0 Td
(few)Tj
1.6157 0 Td
(events,)Tj
2.9537 0 Td
(after)Tj
-35.7502 -1.3039 Td
(240)Tj
1.6441 0 Td
(sec.)Tj
1.6554 0 Td
(Data)Tj
2.1203 0 Td
(were)Tj
2.126 0 Td
(analyzed)Tj
3.702 0 Td
(and)Tj
1.7291 0 Td
(subpopulations)Tj
6.3439 0 Td
(gated)Tj
2.3698 0 Td
(with)Tj
1.9954 0 Td
(FACSDiva)Tj
4.4674 0 Td
(6.1.3)Tj
2.0976 0 Td
(software)Tj
3.583 0 Td
(\(BD)Tj
-33.834 -1.2982 Td
(Biosciences\).)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 400.0251 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Flow)Tj
2.3102 0 Td
(cytometric)Tj
4.7339 0 Td
(determination)Tj
6.2032 0 Td
(of)Tj
1.0441 0 Td
(AnxA1)Tj
3.137 0 Td
(and)Tj
1.8662 0 Td
(GR)Tj
1.7102 0 Td
(expression)Tj
4.9985 0 Td
(in)Tj
-26.0033 -1.1669 Td
(circulating)Tj
4.6583 0 Td
(monocytes)Tj
5.0079 0 Td
(and)Tj
1.8661 0 Td
(lymphocyte)Tj
5.2205 0 Td
(populations)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 369.0141 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(For)Tj
1.627 0 Td
(the)Tj
1.4684 0 Td
(assessment)Tj
4.6091 0 Td
(of)Tj
1.0148 0 Td
(AnxA1)Tj
3.0784 0 Td
(protein)Tj
3.1521 0 Td
(expression)Tj
4.4674 0 Td
(in)Tj
1.0374 0 Td
(leukocyte)Tj
4.0195 0 Td
(subsets,)Tj
3.2825 0 Td
(EDTA)Tj
2.8233 0 Td
(whole)Tj
2.6079 0 Td
(blood)Tj
-33.1878 -1.3039 Td
(\(100)Tj
/F11 1 Tf
1.9842 0 Td
[()]TJ
/F5 1 Tf
(L\))Tj
1.6044 0 Td
(was)Tj
1.7008 0 Td
(incubated)Tj
4.1782 0 Td
(with)Tj
1.9956 0 Td
(CD3-APC/H7)Tj
5.9244 0 Td
(\(clone)Tj
2.7099 0 Td
(SK7\),)Tj
2.4094 0 Td
(CD4-V450)Tj
4.5694 0 Td
(\(clone)Tj
2.7099 0 Td
(RPA-T4\),)Tj
4.0876 0 Td
(CD8-AF)Tj
-33.8738 -1.2982 Td
(700)Tj
1.644 0 Td
(\(clone)Tj
2.7099 0 Td
(RPA-T8\))Tj
3.8608 0 Td
(\(all)Tj
1.491 0 Td
(from)Tj
2.2054 0 Td
(BD)Tj
1.5363 0 Td
(Biosciences\),)Tj
5.3688 0 Td
(CD14-PeCy7)Tj
5.4992 0 Td
(\(clone)Tj
2.7042 0 Td
(M5E2;)Tj
2.863 0 Td
(Biolegend,)Tj
4.4334 0 Td
(Nordic)Tj
-34.316 -1.2983 Td
(Biosite,)Tj
3.1464 0 Td
(Ta)Tj
0 Tc
0.6349 0 Td
()Tj
-0.004 Tc
0.4139 0 Td
(by,)Tj
1.406 0 Td
(Sweden\),)Tj
3.8664 0 Td
(and)Tj
1.7291 0 Td
(CD56-APC)Tj
4.8302 0 Td
(\(clone)Tj
2.7099 0 Td
(B159;)Tj
2.4492 0 Td
(BD)Tj
1.5363 0 Td
(Biosciences\))Tj
5.1477 0 Td
(for)Tj
1.3833 0 Td
(15)Tj
1.1735 0 Td
(min)Tj
1.8539 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.4514 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
-35.7219 -1.2983 Td
(dark.)Tj
2.2733 0 Td
(Erythrocytes)Tj
5.2838 0 Td
(were)Tj
2.1203 0 Td
(lysed)Tj
2.2337 0 Td
(with)Tj
1.9955 0 Td
(FACS)Tj
2.5739 0 Td
(Lysing)Tj
2.8516 0 Td
(Solution)Tj
3.6 0 Td
(\(BD)Tj
1.8765 0 Td
(Biosciences\))Tj
5.142 0 Td
(for)Tj
1.389 0 Td
(10)Tj
1.1679 0 Td
(min)Tj
1.8595 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.4513 0 Td
(in)Tj
-36.7707 -1.3039 Td
(the)Tj
1.4683 0 Td
(dark,)Tj
2.2734 0 Td
(after)Tj
2.0352 0 Td
(which)Tj
2.6532 0 Td
(the)Tj
1.4684 0 Td
(protocols)Tj
3.9571 0 Td
(for)Tj
1.389 0 Td
(surface)Tj
3.0444 0 Td
(and)Tj
1.7348 0 Td
(total)Tj
2.0012 0 Td
(\(i.e.)Tj
1.7008 0 Td
(surface)Tj
3.05 0 Td
(and)Tj
1.7292 0 Td
(cytosolic\))Tj
4.0478 0 Td
(AnxA1)Tj
3.0784 0 Td
(pro-)Tj
-35.6312 -1.2982 Td
(tein)Tj
1.7574 0 Td
(expression)Tj
4.4617 0 Td
(were)Tj
2.126 0 Td
(separated.)Tj
-7.1489 -1.2983 Td
(To)Tj
1.3379 0 Td
(detect)Tj
2.6192 0 Td
(surface)Tj
3.0501 0 Td
(expression)Tj
4.4617 0 Td
(of)Tj
1.0148 0 Td
(AnxA1,)Tj
3.3051 0 Td
(cells)Tj
1.9219 0 Td
(were)Tj
2.1203 0 Td
(first)Tj
1.8028 0 Td
(washed)Tj
3.1805 0 Td
(with)Tj
1.9956 0 Td
(phosphate-buffered)Tj
-28.0061 -1.3039 Td
(saline)Tj
2.5001 0 Td
(\(PBS\))Tj
2.5115 0 Td
(+)Tj
0.7993 0 Td
(0.5%)Tj
2.1544 0 Td
(Fetal)Tj
2.1543 0 Td
(Bovine)Tj
2.999 0 Td
(Serum)Tj
2.8346 0 Td
(\(FBS;)Tj
2.3698 0 Td
(PAA,)Tj
2.3754 0 Td
(Invitrogen,)Tj
4.6658 0 Td
(Carlsbad,)Tj
3.9912 0 Td
(CA,)Tj
1.7914 0 Td
(USA\).)Tj
2.6816 0 Td
(After)Tj
-33.8284 -1.2983 Td
(centrifugation,)Tj
6.1114 0 Td
(unspecific)Tj
4.269 0 Td
(binding)Tj
3.3505 0 Td
(was)Tj
1.7008 0 Td
(blocked)Tj
3.3505 0 Td
(with)Tj
1.9956 0 Td
(goat)Tj
1.9275 0 Td
(serum)Tj
2.7213 0 Td
(\(GIBCO,)Tj
3.8324 0 Td
(Invitrogen\))Tj
4.7848 0 Td
(for)Tj
1.3833 0 Td
(10)Tj
-35.4271 -1.2983 Td
(min)Tj
1.8538 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.4514 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(dark,)Tj
2.2733 0 Td
(before)Tj
2.744 0 Td
(stained)Tj
3.0784 0 Td
(with)Tj
1.9955 0 Td
(rabbit)Tj
2.6079 0 Td
(anti-AnxA1)Tj
4.9776 0 Td
(\(Invitrogen\))Tj
5.1193 0 Td
(for)Tj
1.389 0 Td
(15)Tj
1.1736 0 Td
(min)Tj
1.8538 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.4514 0 Td
(in)Tj
-36.3796 -1.3039 Td
(the)Tj
1.4683 0 Td
(dark.)Tj
2.2734 0 Td
(Cells)Tj
2.1599 0 Td
(were)Tj
2.126 0 Td
(washed)Tj
3.1748 0 Td
(and)Tj
1.7291 0 Td
(then)Tj
2.0183 0 Td
(stained)Tj
3.0841 0 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4684 0 Td
(secondary)Tj
4.2746 0 Td
(goat)Tj
1.9219 0 Td
(anti-rabbit)Tj
4.5014 0 Td
(F\(ab'\))Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 545.6125 224.3338 cm
BT
/F5 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 549.1842 225.9779 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-PE)Tj
-34.9169 -1.2982 Td
(\(Invitrogen\))Tj
5.125 0 Td
(for)Tj
1.3833 0 Td
(15)Tj
1.1735 0 Td
(min)Tj
1.8539 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.4514 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(dark,)Tj
2.2733 0 Td
(washed)Tj
3.1805 0 Td
(and)Tj
1.7291 0 Td
(then)Tj
2.0183 0 Td
(permeabilized/fixed)Tj
8.1637 0 Td
(with)Tj
1.9956 0 Td
(Permea-)Tj
-33.8058 -1.2983 Td
(bilizing)Tj
3.1975 0 Td
(solution)Tj
3.4866 0 Td
(2)Tj
0.6916 0 Td
(\(Perm)Tj
2.7383 0 Td
(2,)Tj
0.9184 0 Td
(BD)Tj
1.5363 0 Td
(Biosciences\))Tj
5.1477 0 Td
(for)Tj
1.3833 0 Td
(10)Tj
1.1736 0 Td
(min)Tj
1.8538 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.4514 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(dark.)Tj
2.2734 0 Td
(After)Tj
2.2903 0 Td
(centrifugation)Tj
-31.6004 -1.3039 Td
(cells)Tj
1.9219 0 Td
(were)Tj
2.1203 0 Td
(resuspended)Tj
5.2327 0 Td
(in)Tj
1.0375 0 Td
(1%)Tj
1.4513 0 Td
(paraformaldehyde)Tj
7.5288 0 Td
(\(PFA\)/PBS)Tj
4.6148 0 Td
(and)Tj
1.7291 0 Td
(kept)Tj
1.9559 0 Td
(at)Tj
0.9524 0 Td
(4C)Tj
1.7518 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(dark)Tj
2.0466 0 Td
(until)Tj
-34.8489 -1.2983 Td
(flow)Tj
1.9446 0 Td
(cytometry)Tj
4.2689 0 Td
(analysis.)Tj
-5.0173 -1.2982 Td
(For)Tj
1.6271 0 Td
(detection)Tj
3.9401 0 Td
(of)Tj
1.0148 0 Td
(total)Tj
2.0013 0 Td
(expression)Tj
4.4673 0 Td
(of)Tj
1.0148 0 Td
(AnxA1)Tj
3.0784 0 Td
(protein,)Tj
3.3789 0 Td
(cells)Tj
1.9162 0 Td
(were)Tj
2.126 0 Td
(permeabilized/fixed)Tj
8.1637 0 Td
(with)Tj
-33.9248 -1.2983 Td
(Perm)Tj
2.3924 0 Td
(2)Tj
0.6973 0 Td
(for)Tj
1.3833 0 Td
(10)Tj
1.1736 0 Td
(min)Tj
1.8538 0 Td
(at)Tj
0.9525 0 Td
(RT)Tj
1.4513 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(dark.)Tj
2.2734 0 Td
(After)Tj
2.2904 0 Td
(centrifugation,)Tj
6.1114 0 Td
(unspecific)Tj
4.269 0 Td
(binding)Tj
3.3505 0 Td
(was)Tj
1.6951 0 Td
(blocked)Tj
3.3561 0 Td
(with)Tj
-35.7559 -1.3039 Td
(goat)Tj
1.9219 0 Td
(serum)Tj
2.7269 0 Td
(for)Tj
1.3833 0 Td
(10)Tj
1.1735 0 Td
(min)Tj
1.8539 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.4513 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(dark,)Tj
2.2733 0 Td
(where)Tj
2.6532 0 Td
(after)Tj
2.0353 0 Td
(cells)Tj
1.9219 0 Td
(were)Tj
2.1203 0 Td
(stained)Tj
3.0784 0 Td
(with)Tj
2.0012 0 Td
(rabbit)Tj
2.6022 0 Td
(anti-AnxA1)Tj
-32.6549 -1.2983 Td
(for)Tj
1.3833 0 Td
(30)Tj
1.1735 0 Td
(min)Tj
1.8539 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.4513 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(dark.)Tj
2.279 0 Td
(After)Tj
2.2847 0 Td
(washing,)Tj
3.7304 0 Td
(cells)Tj
1.9219 0 Td
(were)Tj
2.1203 0 Td
(incubated)Tj
4.1782 0 Td
(with)Tj
1.9956 0 Td
(secondary)Tj
4.2746 0 Td
(antibody)Tj
-32.105 -1.2982 Td
(\(goat)Tj
2.262 0 Td
(anti-rabbit)Tj
4.5014 0 Td
(F\(ab'\))Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 291.2881 107.3196 cm
BT
/F5 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 294.8598 109.0204 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-PE\))Tj
2.0409 0 Td
(for)Tj
1.3833 0 Td
(30)Tj
1.1735 0 Td
(min)Tj
1.8539 0 Td
(at)Tj
0.9524 0 Td
(RT)Tj
1.4513 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(dark,)Tj
2.2791 0 Td
(washed)Tj
3.1748 0 Td
(again)Tj
2.3697 0 Td
(and)Tj
1.7291 0 Td
(subsequently)Tj
-30.3984 -1.3039 Td
(resuspended)Tj
5.2327 0 Td
(in)Tj
1.0318 0 Td
(1%)Tj
1.457 0 Td
(PFA/PBS)Tj
3.9344 0 Td
(and)Tj
1.7291 0 Td
(kept)Tj
1.9559 0 Td
(at)Tj
0.9524 0 Td
(4C)Tj
1.7518 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(dark)Tj
2.0466 0 Td
(until)Tj
2.109 0 Td
(flow)Tj
1.9446 0 Td
(cytometry)Tj
4.2746 0 Td
(analysis.)Tj
3.5489 0 Td
(Sam-)Tj
-34.4746 -1.2982 Td
(ples)Tj
1.7688 0 Td
(without)Tj
3.3278 0 Td
(primary)Tj
3.4583 0 Td
(anti-AnxA1)Tj
4.9718 0 Td
(were)Tj
2.126 0 Td
(used)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(control)Tj
3.1238 0 Td
(for)Tj
1.3889 0 Td
(background)Tj
5.0287 0 Td
(staining.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 445.3228 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Annexin)Tj
3.7701 0 Td
(A1)Tj
1.4244 0 Td
(in)Tj
0.9779 0 Td
(coronary)Tj
4.0394 0 Td
(artery)Tj
2.7355 0 Td
(disease)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01741)Tj
4.089 0 Td
(77)Tj
0 g
2.0906 0 Td
(March)Tj
2.9622 0 Td
(22,)Tj
1.5874 0 Td
(2017)Tj
34.3562 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
64 0 obj
<>stream
endstream
endobj
65 0 obj
<>stream
endstream
endobj
66 0 obj
<>stream
BT
66.402 0 Td
(16)Tj
ET
Q
endstream
endobj
67 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 10 0 R/Annots 70 0 R/Contents 71 0 R/TrimBox[0 0 612 792]>>
endobj
68 0 obj
<>
endobj
72 0 obj
<>stream
/CIDInit/ProcSet findresource begin
12 dict begin begincmap
/CMapName/Adobe-Identity-UCS def
/CIDSystemInfo<>def
/CMapType 2 def
1 begincodespacerange
<0000>
endcodespacerange
3 beginbfchar
<00EF><0394>
<010B><03B1>
<010C><03B2>
endbfchar
endcmap
CMapName currentdict /CMap defineresource pop end end
endstream
endobj
73 0 obj
<>/FontDescriptor 74 0 R/DW 250/W[239[603] 267[578 495]]>>
endobj
74 0 obj
<>
endobj
75 0 obj
<>stream
cvt f6 fpgm2Msf bglyf\> head % 6hhea1 $hmtx&O